Drug ID: | NPD6355 |
Drug Name: | BM-13.1196 |
Molecular Formula: | C25H32O4 |
Canonical SMILES: | COc1ccccc1CCCCCC(C(=O)O)Oc1ccc(cc1)C1CCCC1 |
Standard InCHI: | InChI=1S/C25H32O4/c1-28-23-13-8-7-12-21(23)11-3-2-4-14-24(25(26)27)29-22-17-15-20(16-18-22)19-9-5-6-10-19/h7-8,12-13,15-19,24H,2-6,9-11,14H2,1H3,(H,26,27) |
Standard InCHIKey: | DCHDPGRFIYSFPR-UHFFFAOYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB013767 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 396.23 |
ALogP | -2.0633 |
MLogP | 3.77 |
XLogP | 8.5 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 13 |
TPSA | 55.76 |
RO5 Violation | 2 |